Agilent Prices $750M in Senior Notes | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies said last night that it has priced two series of senior notes offerings with an aggregate principal amount of $750 million.

The first series of $250 million in 2.5 percent notes will mature in July 2013. The second series of $500 million in 5 percent notes will mature in July 2020.

Agilent expects to close the offering on July 20.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.